
GLUE vs DNA
$GLUE vs $DNA head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
GLUE vs DNA: the quick read
- ·GLUE is the larger company by market cap ($896M vs $787M).
- ·DNA has been more active on our scanner (232 vs 66 alerts in 30 days).
- ·DNA has the smaller float (62.0M vs 70.6M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) vs Biological Products, (No Diagnostic Substances)), so they answer to different catalysts and a move in one says little about the other.
- ·DNA draws far more of our scanner's attention, 232 unusual-volume alerts in 30 days against 66, so it is the more actively traded of the two by some distance.
- ·They are closely matched in size, within 14% of each other on market cap, which makes the rest of this table the interesting part.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing GLUE and DNA on TheDesperateTrader.
- Is GLUE or DNA the better stock?
- "Better" depends on your goal, and these two are not alike. GLUE is the larger company by market cap ($896M vs $787M). DNA has been more active on our scanner (232 vs 66 alerts in 30 days). DNA has the smaller float (62.0M vs 70.6M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between GLUE and DNA?
- The differences that matter: they are not in the same business - GLUE is biological products, (no diagnostic substances) and DNA is biological products, (no diagnostic substances); they are similar in size ($896M vs $787M); they trade at very different share prices ($10.55 vs $12.34); GLUE sits at 18% of its 52-week range against 57% for DNA; our scanner flagged GLUE 66 times in the last 30 days against 232 for DNA. Everything above is measured from the latest completed session and SEC filings.
- Which of GLUE and DNA is more active right now?
- Right now GLUE is at about 1.9x its normal volume and DNA is at about 1.2x, so GLUE is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading GLUE or DNA? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore GLUE and DNA comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.